Elekta

74,92SEK +1,85 %
1 investor følger denne virksomhed

Elekta provides medical technology. The company specializes in the development of clinical solutions for the treatment of cancer and brain diseases. Elekta's treatment system and planning software for radiation therapy and radiation surgery as well as other software systems are used in the healthcare industry to identify and analyze various health conditions. Operations are conducted on a global level, with headquarters in Stockholm.

Omsætning
16,87 mia.
EBIT %
8,48 %
P/E
30,33
Udbytteafkast, %
3,2 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
EKTA B
Daglig lav / høj pris
73,94 / 75,8 SEK
Markedsværdi
27,61 mia. SEK
Aktieomsætning
29,8 mio. SEK
Volumen
397 t

Finanskalender

Major Owners
Source: Millistream Market Data AB

OwnerCapitalVotes
Fjärde AP-fonden9,2 %6,8 %
Laurent Leksell fam och bolag5,9 %30,4 %
Premium
Not activated

This content is for our Premium customers only.

Interim report, May–July 2023/24

Selskabsmeddelelse24.08.2023
Year-end report, May–April 2022/23

Selskabsmeddelelse25.05.2023